Titre : Lèpre

Lèpre : Questions médicales fréquentes

Termes MeSH sélectionnés :

Man-Machine Systems
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lèpre : Questions médicales les plus fréquentes", "headline": "Lèpre : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lèpre : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lèpre" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infections à mycobactéries non tuberculeuses", "url": "https://questionsmedicales.fr/mesh/D009165", "about": { "@type": "MedicalCondition", "name": "Infections à mycobactéries non tuberculeuses", "code": { "@type": "MedicalCode", "code": "D009165", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.475" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lèpre multibacillaire", "alternateName": "Leprosy, Multibacillary", "url": "https://questionsmedicales.fr/mesh/D056006", "about": { "@type": "MedicalCondition", "name": "Lèpre multibacillaire", "code": { "@type": "MedicalCode", "code": "D056006", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.475.371.775" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lèpre lépromateuse", "alternateName": "Leprosy, Lepromatous", "url": "https://questionsmedicales.fr/mesh/D015440", "about": { "@type": "MedicalCondition", "name": "Lèpre lépromateuse", "code": { "@type": "MedicalCode", "code": "D015440", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.475.371.775.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Lèpre paucibacillaire", "alternateName": "Leprosy, Paucibacillary", "url": "https://questionsmedicales.fr/mesh/D056005", "about": { "@type": "MedicalCondition", "name": "Lèpre paucibacillaire", "code": { "@type": "MedicalCode", "code": "D056005", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.475.371.850" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lèpre interpolaire", "alternateName": "Leprosy, Borderline", "url": "https://questionsmedicales.fr/mesh/D015439", "about": { "@type": "MedicalCondition", "name": "Lèpre interpolaire", "code": { "@type": "MedicalCode", "code": "D015439", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.475.371.850.249" } } }, { "@type": "MedicalWebPage", "name": "Lèpre tuberculoïde", "alternateName": "Leprosy, Tuberculoid", "url": "https://questionsmedicales.fr/mesh/D015441", "about": { "@type": "MedicalCondition", "name": "Lèpre tuberculoïde", "code": { "@type": "MedicalCode", "code": "D015441", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.475.371.850.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Lèpre", "alternateName": "Leprosy", "code": { "@type": "MedicalCode", "code": "D007918", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Euzenir Nunes Sarno", "url": "https://questionsmedicales.fr/author/Euzenir%20Nunes%20Sarno", "affiliation": { "@type": "Organization", "name": "Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil." } }, { "@type": "Person", "name": "Wim H van Brakel", "url": "https://questionsmedicales.fr/author/Wim%20H%20van%20Brakel", "affiliation": { "@type": "Organization", "name": "NLR, Amsterdam, Netherlands." } }, { "@type": "Person", "name": "Tarun Narang", "url": "https://questionsmedicales.fr/author/Tarun%20Narang", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India." } }, { "@type": "Person", "name": "Sunil Dogra", "url": "https://questionsmedicales.fr/author/Sunil%20Dogra", "affiliation": { "@type": "Organization", "name": "Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India." } }, { "@type": "Person", "name": "Mariana Andrea Hacker", "url": "https://questionsmedicales.fr/author/Mariana%20Andrea%20Hacker", "affiliation": { "@type": "Organization", "name": "Leprosy Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil. marianah@ioc.fiocruz.br." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Intrinsic sense of touch for intuitive physical human-robot interaction.", "datePublished": "2024-08-21", "url": "https://questionsmedicales.fr/article/39167671", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1126/scirobotics.adn4008" } }, { "@type": "ScholarlyArticle", "name": "Evaluating initial usability of a hand augmentation device across a large and diverse sample.", "datePublished": "2024-05-29", "url": "https://questionsmedicales.fr/article/38809995", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1126/scirobotics.adk5183" } }, { "@type": "ScholarlyArticle", "name": "Automated driving experiences, attention, and intentions following extensive on-road usage of a level 2 automation vehicle.", "datePublished": "2024-05-15", "url": "https://questionsmedicales.fr/article/39251279", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jsr.2024.05.002" } }, { "@type": "ScholarlyArticle", "name": "Automation function and malfunction: effects on human performance in accident handling tasks.", "datePublished": "2024-03-05", "url": "https://questionsmedicales.fr/article/38770836", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00140139.2024.2307964" } }, { "@type": "ScholarlyArticle", "name": "Return-to-Manual Performance can be Predicted Before Automation Fails.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36538745", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00187208221147105" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Infections bactériennes et mycoses", "item": "https://questionsmedicales.fr/mesh/D001423" }, { "@type": "ListItem", "position": 4, "name": "Infections bactériennes", "item": "https://questionsmedicales.fr/mesh/D001424" }, { "@type": "ListItem", "position": 5, "name": "Infections bactériennes à Gram positif", "item": "https://questionsmedicales.fr/mesh/D016908" }, { "@type": "ListItem", "position": 6, "name": "Infections à Actinomycetales", "item": "https://questionsmedicales.fr/mesh/D000193" }, { "@type": "ListItem", "position": 7, "name": "Infections à Mycobacterium", "item": "https://questionsmedicales.fr/mesh/D009164" }, { "@type": "ListItem", "position": 8, "name": "Infections à mycobactéries non tuberculeuses", "item": "https://questionsmedicales.fr/mesh/D009165" }, { "@type": "ListItem", "position": 9, "name": "Lèpre", "item": "https://questionsmedicales.fr/mesh/D007918" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lèpre - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lèpre", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lèpre", "description": "Comment diagnostique-t-on la lèpre ?\nQuels tests sont utilisés pour la lèpre ?\nLa lèpre est-elle contagieuse ?\nQuels signes cliniques indiquent la lèpre ?\nPeut-on détecter la lèpre par des analyses sanguines ?", "url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Man-Machine+Systems&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lèpre", "description": "Quels sont les symptômes de la lèpre ?\nLa lèpre cause-t-elle des douleurs ?\nLes lésions de la lèpre sont-elles douloureuses ?\nComment évoluent les symptômes de la lèpre ?\nPeut-on avoir des symptômes sans être contagieux ?", "url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Man-Machine+Systems&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lèpre", "description": "Comment prévenir la lèpre ?\nLes vaccins protègent-ils contre la lèpre ?\nFaut-il éviter les personnes atteintes de lèpre ?\nQuelles mesures de santé publique sont prises ?\nLa lèpre est-elle une maladie évitable ?", "url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Man-Machine+Systems&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lèpre", "description": "Quel est le traitement de la lèpre ?\nLa lèpre peut-elle être guérie ?\nCombien de temps dure le traitement de la lèpre ?\nY a-t-il des effets secondaires au traitement ?\nLe traitement de la lèpre est-il gratuit ?", "url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Man-Machine+Systems&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lèpre", "description": "Quelles sont les complications de la lèpre ?\nLa lèpre peut-elle entraîner des handicaps ?\nLes complications sont-elles réversibles ?\nComment gérer les complications de la lèpre ?\nLes complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Man-Machine+Systems&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lèpre", "description": "Qui est à risque de développer la lèpre ?\nL'immunité joue-t-elle un rôle dans la lèpre ?\nLes enfants sont-ils plus à risque ?\nLe statut socio-économique influence-t-il le risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Man-Machine+Systems&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la lèpre ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des tests cutanés pour détecter les bacilles." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la lèpre ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de sensibilité cutanée et des biopsies peuvent être réalisés pour confirmer la lèpre." } }, { "@type": "Question", "name": "La lèpre est-elle contagieuse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La lèpre n'est pas très contagieuse; elle se propage par contact prolongé avec une personne infectée." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent la lèpre ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des lésions cutanées, des engourdissements et des déformations peuvent indiquer la lèpre." } }, { "@type": "Question", "name": "Peut-on détecter la lèpre par des analyses sanguines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les analyses sanguines ne sont pas spécifiques; le diagnostic repose principalement sur l'examen clinique." } }, { "@type": "Question", "name": "Quels sont les symptômes de la lèpre ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des lésions cutanées, des engourdissements et des douleurs nerveuses." } }, { "@type": "Question", "name": "La lèpre cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la lèpre peut provoquer des douleurs nerveuses et des sensations anormales." } }, { "@type": "Question", "name": "Les lésions de la lèpre sont-elles douloureuses ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les lésions cutanées sont souvent indolores, mais peuvent s'infecter et causer des douleurs." } }, { "@type": "Question", "name": "Comment évoluent les symptômes de la lèpre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent évoluer lentement, avec des périodes d'aggravation et d'amélioration." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans être contagieux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une personne peut avoir des symptômes sans être contagieuse, surtout en début d'infection." } }, { "@type": "Question", "name": "Comment prévenir la lèpre ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention repose sur le dépistage précoce et le traitement des personnes infectées." } }, { "@type": "Question", "name": "Les vaccins protègent-ils contre la lèpre ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de vaccin spécifique contre la lèpre, mais des recherches sont en cours." } }, { "@type": "Question", "name": "Faut-il éviter les personnes atteintes de lèpre ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Non, avec un traitement, les personnes atteintes ne sont plus contagieuses et peuvent être approchées." } }, { "@type": "Question", "name": "Quelles mesures de santé publique sont prises ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et de dépistage sont mises en place pour contrôler la lèpre." } }, { "@type": "Question", "name": "La lèpre est-elle une maladie évitable ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la lèpre est évitable grâce à un diagnostic précoce et un traitement adéquat." } }, { "@type": "Question", "name": "Quel est le traitement de la lèpre ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard est une polychimiothérapie (PCT) avec des antibiotiques comme la rifampicine." } }, { "@type": "Question", "name": "La lèpre peut-elle être guérie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la lèpre est curable avec un traitement approprié et précoce." } }, { "@type": "Question", "name": "Combien de temps dure le traitement de la lèpre ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dure généralement de 6 mois à 2 ans, selon la forme de la maladie." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires au traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires peuvent survenir, mais ils sont généralement légers et gérables." } }, { "@type": "Question", "name": "Le traitement de la lèpre est-il gratuit ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Dans de nombreux pays, le traitement de la lèpre est gratuit et accessible." } }, { "@type": "Question", "name": "Quelles sont les complications de la lèpre ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions nerveuses, des déformations et des infections secondaires." } }, { "@type": "Question", "name": "La lèpre peut-elle entraîner des handicaps ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des lésions nerveuses peuvent causer des handicaps permanents si non traitées." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non." } }, { "@type": "Question", "name": "Comment gérer les complications de la lèpre ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite un suivi médical et des soins adaptés aux lésions." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Qui est à risque de développer la lèpre ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes vivant dans des zones endémiques et celles en contact avec des malades sont à risque." } }, { "@type": "Question", "name": "L'immunité joue-t-elle un rôle dans la lèpre ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une immunité affaiblie augmente le risque de développer la lèpre." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent être à risque, mais la maladie touche principalement les adultes." } }, { "@type": "Question", "name": "Le statut socio-économique influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un faible statut socio-économique est associé à un risque accru de lèpre." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées ont un risque accru de contracter la lèpre." } } ] } ] }

Sources (10000 au total)

Automated driving experiences, attention, and intentions following extensive on-road usage of a level 2 automation vehicle.

An on-road study was conducted to examine the effects of level 2 automation on the stressfulness and enjoyment of driving and driving attention following prolonged usage. The study also examined the c... Motorists who had never used automated systems drove a level 2 automation vehicle for a 6-8 week period.... Participants reported that the automated systems reduced the stress of driving and made traveling more enjoyable and relaxing. They also reported that the automation did not make traveling boring and ... Although some of the findings suggest that automated systems increase unsafe behavior by novice users, other facets of the surveys suggest that motorists are cognizant of the risks of automated drivin...

Return-to-Manual Performance can be Predicted Before Automation Fails.

This study aimed to examine operator state variables (workload, fatigue, and trust in automation) that may predict return-to-manual (RTM) performance when automation fails in simulated air traffic con... Prior research has largely focused on triggering adaptive automation based on reactive indicators of performance degradation or operator strain. A more direct and effective approach may be to proactiv... Participants accepted and handed-off aircraft from their sector and were assisted by imperfect conflict detection/resolution automation. To avoid aircraft conflicts, participants were required to inte... For participants with the same or higher average trust than the sample average, an increase in their trust (relative to their own average) slowed their subsequent RTM response time. For participants w... RTM performance degraded as trust in automation increased relative to participants' own average, but only for individuals with average or high levels of trust.... Study outcomes indicate a potential for future adaptive automation systems to detect vulnerable operator states in order to predict subsequent RTM performance decrements....